Francisco joined DILIsym Services, a division of Simulations Plus in September 2022 as a Scientist I. His primary focus is on development, implementation, and execution of quantitative systems pharmacology (QSP) models within various Simulations Plus platforms (NAFLDsym, IPFsym, and ILDsym).
Prior to DILIsym Services, Francisco pursued a PhD in Bioengineering from the University of Notre Dame (anticipated degree conferral in January 2023). In his graduate work, he developed computational models and platforms for understanding multicellular systems biology and advancing preclinical therapeutic screening. He received a research master’s degree in Applied Computational Mathematics and Statistics from the University of Notre Dame. His primary research works involved simulation and implementation of mechanistic models in developing epithelial tissue, development of high-throughput therapeutic screening platforms, and creation of data processing pipelines utilizing machine learning. As a result of his research, he earned numerous fellowship and grant awards. Francisco also received a Bachelor of Science degree in Chemical and Biomolecular Engineering alongside a Bachelor of Science degree in Applied Computational Mathematics and Statistics.